---
title: "Sinopharm Group Co (SHTDF) Gets a Buy from CLSA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284466436.md"
description: "CLSA analyst maintained a Buy rating on Sinopharm Group Co yesterday and set a price target of HK$25.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Sinopharm Group Co is a Strong Buy with an average price target of HK$23.51."
datetime: "2026-04-29T00:26:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284466436.md)
  - [en](https://longbridge.com/en/news/284466436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284466436.md)
---

# Sinopharm Group Co (SHTDF) Gets a Buy from CLSA

CLSA analyst maintained a Buy rating on Sinopharm Group Co yesterday and set a price target of HK$25.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Sinopharm Group Co is a Strong Buy with an average price target of HK$23.51.

### Related Stocks

- [01099.HK](https://longbridge.com/en/quote/01099.HK.md)

## Related News & Research

- [Sinopharm posts unaudited Q1 2026 figures, highlighting RMB 400.8bn asset base](https://longbridge.com/en/news/284128644.md)
- [This Analyst Just Sent Mobileye Stock Down. Here's Why.](https://longbridge.com/en/news/286817003.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Do Wall Street Analysts Like Equity Residential Stock?](https://longbridge.com/en/news/286806057.md)
- [Positive Report for Sinotruk Hong Kong (3808) from Bank of America Securities](https://longbridge.com/en/news/286848185.md)